Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Metch

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Cancer Treatment Reports|July 1, 1987
Platinum analogs in recurrent and advanced head and neck cancer: a Southwest Oncology Group and Wayne State University StudyM Al-Sarraf, B Metch, J Kish, et al.
Journal of Interferon Research|October 1, 1990
Phase II evaluation of recombinant interferon-beta (IFN-beta ser) in patients with diffuse mesothelioma: a Southwest Oncology Group studyD D Von Hoff, B Metch, J G Lucas, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Phase II trial of ifosfamide and cisplatin in the treatment of metastatic sarcomas: a Southwest Oncology Group studyG T Budd, B Metch, S A Weiss, et al.
Cancer|November 15, 1992
A phase II evaluation of ifosfamide and mesna in unresectable diffuse malignant mesothelioma. A Southwest Oncology Group studyB L Zidar, B Metch, S P Balcerzak, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 1, 1993
The Carotene and Retinol Efficacy Trial (CARET) to prevent lung cancer in high-risk populations: pilot study with asbestos-exposed workersG S Omenn, G E Goodman, M D Thornquist, et al.
Vaccine|February 2, 2013
Does participation in an HIV vaccine efficacy trial affect risk behaviour in South Africa?G E Gray, B Metch, G Churchyard, et al.
Medical and Pediatric Oncology|January 1, 1988
VP-16 + adriamycin vs. adriamycin alone in advanced adenocarcinoma of the breast, phase II, a randomized trial: a Southwest Oncology Group StudyC B Vaughn, S J Green, R O'Bryan, et al.
Journal of the National Cancer Institute|July 3, 1991
Phase III comparison of doxorubicin and dacarbazine given by bolus versus infusion in patients with soft-tissue sarcomas: a Southwest Oncology Group studyM Zalupski, B Metch, S Balcerzak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1989
Adjuvant CMFVP versus melphalan for operable breast cancer with positive axillary nodes: 10-year results of a Southwest Oncology Group StudyS E Rivkin, S Green, B Metch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1993
One versus 2 years of CMFVP adjuvant chemotherapy in axillary node-positive and estrogen receptor-negative patients: a Southwest Oncology Group studyS E Rivkin, S Green, B Metch, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Cancer Treatment Reports|July 1, 1987
Platinum analogs in recurrent and advanced head and neck cancer: a Southwest Oncology Group and Wayne State University StudyM Al-Sarraf, B Metch, J Kish, et al.
Journal of Interferon Research|October 1, 1990
Phase II evaluation of recombinant interferon-beta (IFN-beta ser) in patients with diffuse mesothelioma: a Southwest Oncology Group studyD D Von Hoff, B Metch, J G Lucas, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Phase II trial of ifosfamide and cisplatin in the treatment of metastatic sarcomas: a Southwest Oncology Group studyG T Budd, B Metch, S A Weiss, et al.
Cancer|November 15, 1992
A phase II evaluation of ifosfamide and mesna in unresectable diffuse malignant mesothelioma. A Southwest Oncology Group studyB L Zidar, B Metch, S P Balcerzak, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 1, 1993
The Carotene and Retinol Efficacy Trial (CARET) to prevent lung cancer in high-risk populations: pilot study with asbestos-exposed workersG S Omenn, G E Goodman, M D Thornquist, et al.
Vaccine|February 2, 2013
Does participation in an HIV vaccine efficacy trial affect risk behaviour in South Africa?G E Gray, B Metch, G Churchyard, et al.
Medical and Pediatric Oncology|January 1, 1988
VP-16 + adriamycin vs. adriamycin alone in advanced adenocarcinoma of the breast, phase II, a randomized trial: a Southwest Oncology Group StudyC B Vaughn, S J Green, R O'Bryan, et al.
Journal of the National Cancer Institute|July 3, 1991
Phase III comparison of doxorubicin and dacarbazine given by bolus versus infusion in patients with soft-tissue sarcomas: a Southwest Oncology Group studyM Zalupski, B Metch, S Balcerzak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1989
Adjuvant CMFVP versus melphalan for operable breast cancer with positive axillary nodes: 10-year results of a Southwest Oncology Group StudyS E Rivkin, S Green, B Metch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1993
One versus 2 years of CMFVP adjuvant chemotherapy in axillary node-positive and estrogen receptor-negative patients: a Southwest Oncology Group studyS E Rivkin, S Green, B Metch, et al.
Pageof 3